<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-ijms-21-09049">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Luo</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Xiao</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhong</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hongde</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Grifolin directly targets ERK1/2 to epigenetically suppress cancer cell metastasis</article-title>
  <source>Oncotarget</source>
  <year>2015</year>
  <volume>6</volume>
  <fpage>42704</fpage>
  <lpage>42716</lpage>
  <pub-id pub-id-type="doi">10.18632/oncotarget.5678</pub-id>
  <?supplied-pmid 26516701?>
  <pub-id pub-id-type="pmid">26516701</pub-id>
 </element-citation>
</ref>
